Mixed news on Vyvanse shortage

There has been good, and bad, news about the ongoing shortage of the ADHD treatment The Therapeutic Goods Administration (TGA) has an update informing of mixed news about ongoing shortages of Vyvanse (lisdexamfetamine dimesilate) capsules, with a resolution achieved for one strength of the drug, while the shortage of another has been extended. In a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Man hurls abuse at CWH staff
Next ‘We hear and value all voices’